JFG
MGNX icon

Jefferies Financial Group’s MacroGenics MGNX Stock Holding History

Jefferies Financial Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,000
Closed -$213K – 1638
2024
Q2 		$213K Buy
+50,000
New +$487K ﹤0.01% 1214

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Jefferies Financial Group's MGNX Position: Q1 2026 in Review

Jefferies Financial Group sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 1,841,172 shares — an estimated $2.96M sold.

Jefferies Financial Group first reported a position in MGNX in Q2 2024 and held it in 3 quarters. The position peaked at $2.96M in Q4 2025. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Jefferies Financial Group reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 1,841,172 MacroGenics shares in Q1 2026, an estimated $2.96M.
  • Jefferies Financial Group first reported a position in MacroGenics in Q2 2024 and held it in 3 quarters.
  • Jefferies Financial Group's MacroGenics position peaked at $2.96M in Q4 2025.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.